Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses

Vesicular stomatitis virus (VSV), like many other Rhabdoviruses, have become the focus of intense research over the past couple of decades based on their suitability as vaccine vectors, transient gene delivery systems, and as oncolytic viruses for cancer therapy. VSV as a vaccine vector platform has...

Descripción completa

Detalles Bibliográficos
Autores principales: Racine, Trina, Kobinger, Gary P., Arts, Eric J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594459/
https://www.ncbi.nlm.nih.gov/pubmed/28893277
http://dx.doi.org/10.1186/s12981-017-0179-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594459/
https://www.ncbi.nlm.nih.gov/pubmed/28893277
http://dx.doi.org/10.1186/s12981-017-0179-2

Ejemplares similares